🧾 What This Document Is

This is a DEFA14A filing, also known as "Definitive Additional Materials." Think of it as an update or add-on to the main proxy statement a company sends to its shareholders.

👉 In simple terms: SunOpta is announcing a major regulatory update about its sale to another company, Refresco. This filing isn't the full rulebook; it's a quick, official news release to keep shareholders informed.

🏢 What The Company Does

SunOpta Inc. (Nasdaq: STKL, TSX: SOY) is a North American company that helps big brands, retailers, and restaurants manage their food and drink supply chains.

👉 In simple terms: They are a behind-the-scenes partner that provides ingredients, packaging, and innovation for things like beverages, broths, and healthy snacks. They've been doing this for over 50 years.

🤝 The Deal

SunOpta is being acquired by Refresco, a major beverage producer. The price is US$6.50 per share in cash.

• The Agreement: This deal was officially signed on February 6, 2026.
• The Buyers: Refresco is buying SunOpta through a special company called Pegasus BidCo B.V.

🚀 Key Regulatory Milestone

The big news in this filing is that a critical regulatory hurdle has been cleared.

• What Happened: The waiting period under the Hart-Scott-Rodino (HSR) Antitrust Act ended early on April 10, 2026.
• Why It Matters: The HSR Act is like a mandatory "pause button" for big mergers, letting U.S. regulators review if the deal would hurt competition. Early termination is a green light—it means the U.S. government has no major antitrust concerns and will not block the deal on those grounds.

🔮 What's Next?

Clearing the HSR review is one important box checked, but the deal isn't done yet.

The closing of the sale still depends on:

1. Getting other required regulatory approvals.
2. Getting a "yes" vote from SunOpta's shareholders.
3. Getting final approval from the Ontario Superior Court of Justice (since SunOpta is also listed in Canada).
4. Meeting other standard conditions of the deal.

⚖️ Big Picture: Strengths & Risks

👍 Strengths / Positive Signals:

• The smooth early termination of the HSR review suggests a straightforward regulatory path in the U.S., reducing one source of uncertainty.
• The deal provides a clear cash payout for shareholders at a fixed price.

⚠️ Risks to Watch:

• The deal still faces several other conditions. Shareholders could vote it down, or another regulatory body could raise issues.
• Mergers can be complex and take time to finalize, during which the business must operate as usual.

💡 Why This Matters

This filing is a progress report on a major corporate event—the sale of the company. For investors and followers, it confirms the deal is moving forward on schedule and has passed a significant U.S. regulatory check, which generally increases the likelihood of completion.

🧠 The Analogy

Imagine SunOpta is a house for sale. The HSR review was like the city's building inspection. Getting "early termination" means the inspector gave it a quick pass with no major code violations. But the sale still needs the buyers' mortgage to be approved (financing), the homeowners association to agree (shareholder vote), and a final sign-off from the lawyers (court approval) before the keys are handed over.

🧩 Final Takeaway

SunOpta's sale to Refresco hit a positive milestone with U.S. antitrust clearance. The $6.50 per share deal is on track but awaits shareholder, court, and other regulatory approvals before it's final.